JOHN C BURNETT, M.D.
Osteopathic Medicine at 1 St, Rochester, MN
License number
Minnesota 23023
Category
Osteopathic Medicine
Type
Cardiovascular Disease
Address
Address
200 1St St SW, Rochester, MN 55905
Phone
(507) 284-2511
Organization information
See more information about JOHN C BURNETT at bizstanding.comJohn C Burnett MD
1917 Greenfield Ln SW, Rochester, MN 55902
Categories:
Internal Medicine Physicians & Surgeons
Phone:
(507) 288-2807 (Phone)
Mayo Clinic - John C Burnett JR MD
200 1 St SW #W4, Rochester, MN 55905
Categories:
Physicians & Surgeons
Phone:
(507) 284-2511 (Phone)
Professional information
Marriott Family Professor Of Cv Research At Mayo Clinic
Position:
Marriott Family Professor of CV Research at Mayo Clinic
Location:
Rochester, Minnesota Area
Industry:
Research
Work:
Mayo Clinic
-
Marriott Family Professor of CV Research
Dr. John C Burnett, Rochester MN - MD (Doctor of Medicine)
Specialties:
Internal Medicine
Address:
Mayo Clinic
200 1St St SW, Rochester 55905
(507) 284-2511 (Phone)
200 1St St SW, Rochester 55905
(507) 284-2511 (Phone)
Certifications:
Internal Medicine, 1978
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Mayo Clinic
200 1St St SW, Rochester 55905
Mayo Clinic Saint Marys Hospital
1216 2Nd St South #West, Rochester 55902
200 1St St SW, Rochester 55905
Mayo Clinic Saint Marys Hospital
1216 2Nd St South #West, Rochester 55902
Education:
Medical School
Loyola University Of Chicago/Stritch School Of Medicine
Graduated: 1974
Mayo Grad School Med/Mayo Fndn
Loyola University Of Chicago/Stritch School Of Medicine
Graduated: 1974
Mayo Grad School Med/Mayo Fndn
Aquaretic And Natriuretic Polypeptides Lacking Vasodilatory Activity
US Patent:
2010019, Aug 5, 2010
Filed:
Sep 7, 2007
Appl. No.:
12/440053
Inventors:
Horng H. Chen - Rochester MN, US
John C. Burnett - Rochester MN, US
John C. Burnett - Rochester MN, US
International Classification:
A61K 38/17, C07K 14/435, C07H 21/04, C12N 15/63, C12N 5/10, A61P 9/10
US Classification:
514 12, 530324, 536 235, 4353201, 435325
Abstract:
This document provides aquaretic and natriuretic polypeptides. For example, this document provides polypeptides having aquaretic and/or natriuretic activities. In some cases, a polypeptide provided herein can have aquaretic and natriuretic activities, while lacking the ability to lower blood pressure. This document also provides methods and materials for inducing aquaretic and/or natriuretic activities within a mammal.
Vasonatrin Peptide And Analogs Thereof
US Patent:
5583108, Dec 10, 1996
Filed:
Aug 29, 1994
Appl. No.:
8/297330
Inventors:
Chi-Ming Wei - Rochester MN
John C. Burnett - Rochester MN
John C. Burnett - Rochester MN
Assignee:
Mayo Foundation for Medical Education and Research - Rochester MN
International Classification:
A61K 3816, C07K 1400, C07K 1458
US Classification:
514 12
Abstract:
Synthetic analogs of C-type natriuretic peptide are provided, together with methods for their production and use as natriuretics, diuretics, and/or vasodilators, or as intermediates for or modulators of such useful compounds or of native natriuretic peptides.
Type V Phosphodiesterase Inhibitors And Natriuretic Polypeptides
US Patent:
2008003, Feb 7, 2008
Filed:
Aug 27, 2007
Appl. No.:
11/845535
Inventors:
John Burnett - Rochester MN, US
Horng Chen - Rochester MN, US
Horng Chen - Rochester MN, US
Assignee:
MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH - Rochester MN
International Classification:
A61K 38/18, A61K 31/519
US Classification:
514012000, 514252160, 514262100
Abstract:
This document provides methods and materials related to PDE V inhibitors, natriuretic polypeptides, and combinations thereof. For example, compositions containing one or more PDE V inhibitors in combination with one or more natriuretic polypeptides are provided herein. In addition, methods for using PDE V inhibitors, natriuretic polypeptides, and combinations thereof to influence heart or renal activities within a mammal are provided herein.
Type V Phosphodiesterase Inhibitors And Natriuretic Polypeptides
US Patent:
2007004, Feb 22, 2007
Filed:
Aug 17, 2006
Appl. No.:
11/465380
Inventors:
John Burnett - Rochester MN, US
Horng Chen - Rochester MN, US
Horng Chen - Rochester MN, US
Assignee:
Mayo Foundation for Medical Education and Research - Rochester MN
International Classification:
A61K 38/17, A61K 31/519
US Classification:
514012000, 514252160
Abstract:
This document provides methods and materials related to PDE V inhibitors, natriuretic polypeptides, and combinations thereof. For example, compositions containing one or more PDE V inhibitors in combination with one or more natriuretic polypeptides are provided herein. In addition, methods for using PDE V inhibitors, natriuretic polypeptides, and combinations thereof to influence heart or renal activities within a mammal are provided herein.
Diuretic And Natriuretic Polypeptides
US Patent:
2010020, Aug 12, 2010
Filed:
Aug 8, 2007
Appl. No.:
12/376880
Inventors:
Robert D. Simari - Rochester MN, US
Shuchong Pan - Rochester MN, US
John C. Burnett - Rochester MN, US
Shuchong Pan - Rochester MN, US
John C. Burnett - Rochester MN, US
International Classification:
A61K 38/22, C07K 14/58, A61P 13/00, C12N 15/63, C12N 5/10
US Classification:
514 12, 530324, 4353201, 435325
Abstract:
This document provides diuretic and natriuretic polypeptides. For example, this document provides polypeptides having diuretic and/or natriuretic activities. In some cases, a polypeptide provided herein can have diuretic and natriuretic activities, while lacking the ability to lower blood pressure. This document also provides methods and materials for inducing diuretic and/or natriuretic activities within a mammal.
Chimeric Natriuretic Peptides
US Patent:
2005005, Mar 17, 2005
Filed:
Sep 23, 2004
Appl. No.:
10/947730
Inventors:
John Burnett - Rochester MN, US
Ondrej Lisy - Rochester MN, US
Ondrej Lisy - Rochester MN, US
International Classification:
A61K038/16, A61K038/18
US Classification:
514012000, 514014000, 530324000, 530327000
Abstract:
Peptides of , including chimeric peptides thereof, are provided, as well as methods of using the peptides as natriuretics, diuretics, and/or vasodilators.
Chimeric Natriuretic Peptides
US Patent:
2003006, Apr 10, 2003
Filed:
Mar 26, 2002
Appl. No.:
10/106806
Inventors:
John Burnett - Rochester MN, US
Ondrej Lisy - Rochester MN, US
Ondrej Lisy - Rochester MN, US
International Classification:
A61K038/10, C07K007/08
US Classification:
514/014000, 530/327000
Abstract:
Peptides of Dendroaspis, including chimeric peptides thereof, are provided, as well as methods of using the peptides as natriuretics, diuretics, and/or vasodilators.
Naturiuretic Polypeptides
US Patent:
2011028, Nov 17, 2011
Filed:
Oct 21, 2009
Appl. No.:
13/125772
Inventors:
Deborah Dickey - Minneapolis MN, US
John C. Burnett - Rochester MN, US
Lincoln R. Potter - Roseville MN, US
John C. Burnett - Rochester MN, US
Lincoln R. Potter - Roseville MN, US
International Classification:
C07K 14/435, C07K 7/08, C07K 7/06
US Classification:
530324, 530330, 530326, 530327
Abstract:
This document provides natriuretic polypeptides. For example, this document provides polypeptides having a natriuretic activity. In some cases, a polypeptide provided herein can have natriuretic activities without lowering blood pressure. Methods and materials for inducing natriuretic activities within a mammal also are provided.